General MedicationsINJECTIONGeneric
CHROMALBIN
ALBUMIN CHROMATED CR-51 SERUM
Standard Dose
100uCi/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview CHROMALBIN is listed in Drugs@FDA under application 017835 (BLA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient ALBUMIN CHROMATED CR-51 SERUM Form and strength INJECTABLE;INJECTION - 100uCi/VIAL Sponsor ISO TEX Submission history Latest submission status date: 1986-07-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview CHROMALBIN is listed in Drugs@FDA under application 017835 (BLA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient ALBUMIN CHROMATED CR-51 SERUM Form and strength INJECTABLE;INJECTION - 100uCi/VIAL Sponsor ISO TEX Submission history Latest submission status date: 1986-07-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.